Back
ProShares UltraShort MSCI Emerging Markets Vs. Akero Therapeutics Industry Stock Comparison
Sell
18
EEV
ProShares UltraShort MSCI Emerging Markets
Last Price:
$12.13
Seasonality Move:
2.51%
Buy
59
AKRO
Akero Therapeutics
Last Price:
$54.36
Seasonality Move:
45.38%
Sell
18
ProShares UltraShort MSCI Emerging Markets (EEV)
is a Sell
Is ProShares UltraShort MSCI Emerging Markets a Buy, Sell or Hold?
-
The current ProShares UltraShort MSCI Emerging Markets [EEV] share price is $12.20. The Score for EEV is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
EEV is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
59
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $53.60. The Score for AKRO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EEV Stock Price Chart
What is ProShares UltraShort MSCI Emerging Markets's stock price today?
-
The ProShares UltraShort MSCI Emerging Markets share price today is $12.20Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EEV is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $53.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
EEV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.37 | Buy |
Relative Strength Index (14 RSI): | 32.65 | Sell |
Chaikin Money Flow: | -5957 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.31 - 13.21) | Sell |
Bollinger Bands (100): | (13.12 - 16.4) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.39 | Buy |
Relative Strength Index (14 RSI): | 56.26 | Buy |
Chaikin Money Flow: | 1035840 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.71 - 55.13) | Buy |
Bollinger Bands (100): | (40.15 - 52.15) | Buy |
EEV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.41 | Sell |
20-day SMA: | 12.66 | Sell |
50-day SMA: | 13.41 | Sell |
200-day SMA: | 15.51 | Sell |
8-day EMA: | 10.22 | Buy |
20-day EMA: | 6.23 | Buy |
50-day EMA: | 3.02 | Buy |
200-day EMA: | 0.84 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.84 | Buy |
20-day SMA: | 53.15 | Buy |
50-day SMA: | 49.65 | Buy |
200-day SMA: | 39.59 | Buy |
8-day EMA: | 52.37 | Buy |
20-day EMA: | 52.37 | Buy |
50-day EMA: | 50.12 | Buy |
200-day EMA: | 41.33 | Buy |
ProShares UltraShort MSCI Emerging Markets Earnings Growth & EEV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
ProShares UltraShort MSCI Emerging Markets Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |